Cargando…
Targeting Glioblastoma via Selective Alteration of Mitochondrial Redox State
SIMPLE SUMMARY: Glioblastoma is characterized by a pronounced redox imbalance due to elevated glycolytic and mitochondrial oxidative metabolism. New therapeutic strategies have been developed to modulate glioblastoma redox signaling to effectively suppress growth and prolong survival. However, drug...
Autores principales: | Sumiyoshi, Akira, Shibata, Sayaka, Zhelev, Zhivko, Miller, Thomas, Lazarova, Dessislava, Aoki, Ichio, Obata, Takayuki, Higashi, Tatsuya, Bakalova, Rumiana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833725/ https://www.ncbi.nlm.nih.gov/pubmed/35158753 http://dx.doi.org/10.3390/cancers14030485 |
Ejemplares similares
-
Tolerable treatment of glioblastoma with redox-cycling ‘mitocans': a comparative study in vivo
por: Sumiyoshi, Akira, et al.
Publicado: (2023) -
Redox-Cycling “Mitocans” as Effective New Developments in Anticancer Therapy
por: Bakalova, Rumiana, et al.
Publicado: (2023) -
Over-Reduced State of Mitochondria as a Trigger of “β-Oxidation Shuttle” in Cancer Cells
por: Zhelev, Zhivko, et al.
Publicado: (2022) -
A “Weird” Mitochondrial Fatty Acid Oxidation as a Metabolic “Secret” of Cancer
por: Zhelev, Zhivko, et al.
Publicado: (2022) -
Corrigendum to “Cellular redox imbalance on the crossroad between mitochondrial dysfunction, senescence, and proliferation” [Redox Biol. 53 (2022) 102337]
por: Bakalova, Rumiana, et al.
Publicado: (2022)